The woman who could impede RFK Jr.'s anti-vaccine agenda
Susan Monarez might end up being one of the most important people in President Donald Trump's administration. As acting director of the Centers for Disease Control and Prevention and the nominee to hold the position permanently, she has the power to frustrate the anti-vaccine agenda of Health and Human Services Secretary Robert F. Kennedy Jr.
Based on her performance at her confirmation hearing on Wednesday, she might just be up to that task.
Monarez was nominated after senators balked at the anti-vaccine positions of Dave Weldon, Trump's first choice for the job. She would be the first person without a medical degree to fill the role, but she is a well-respected scientist with a doctorate in microbiology and immunology. She also served as deputy director of the Advanced Research Projects Agency for Health.
Most important, she has no record suggesting she subscribes to the vaccine skepticism that Kennedy and many of his newly appointed allies at the CDC have expressed. 'I think vaccines save lives,' she said at her confirmation hearing. She also defended mRNA vaccines, the technology that was used to quickly develop shots against the coronavirus, as 'safe' and insisted she has 'no a priori prejudices against mRNA platform or any other approach that is being taken to develop vaccines.'
Monarez spent much of the hearing artfully dodging difficult questions about Kennedy's actions. Regarding his decision to fire everyone on the CDC's Advisory Committee on Immunization Practices and replace them with his own hand-selected advisers, many of whom have criticized vaccines, she offered a cagey response: 'I agree that the secretary had to make a decision related to ensuring that the ACIP could be supportive of restoring public trust in decision-making.'
She also said the committee has 'a very vital role to play, and it must make sure that it is using science and evidence to drive that decision-making.' And she insisted its members must go through the proper ethics approval process before participating in meetings.
That's probably the best response the public could hope for from a Trump nominee. She deftly managed not to contradict Kennedy's decisions but also avoided strongly endorsing them. She sent an important signal: She could be a real impediment to those seeking to upend vaccine policies that have saved countless lives.
No recommendation from ACIP can become government policy without sign-off from the CDC director. If, for example, the committee reviews the childhood vaccine schedule or long-standing immunizations — as its new chair announced it would do on Wednesday — and determines that children shouldn't be receiving certain vaccines at certain times, despite all the evidence to the contrary, Monarez could reject that finding. She could also use her position to press for trusted voices to serve on the committee and push back against false information about vaccines.
Of course, there is no guarantee that Monarez would do all this. Trump appointees, including Kennedy, have a history of saying reassuring things about vaccines during their confirmation hearings, only to change course when in office. Nevertheless, the public would be better-off with a serious person such as Monarez at the CDC's helm.
The Senate should confirm her, and fast. Monarez, meanwhile, needs to recognize the burden she is accepting. Being CDC director is not an easy job, even in less contentious times. Having to report to Kennedy makes it incalculably harder. Lives will depend on whether Monarez resists Kennedy's efforts to make America sick again. If she's not willing to do that, she should step aside.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New York Times
21 minutes ago
- New York Times
Justice Department Says the Trump Administration Plans to Re-Deport Abrego Garcia
Less than three weeks after Kilmar Armando Abrego Garcia was brought back from a wrongful deportation to El Salvador to face criminal charges in the United States, the Trump administration indicated on Thursday that it planned to deport him again — this time to a different country. Jonathan Guynn, a Justice Department lawyer, acknowledged to a judge that there were 'no imminent plans' to remove Mr. Abrego Garcia. Still, the assertion that the administration intends to re-deport a man who was just returned to the country after being indicted raised questions about the charges the Justice Department filed against him. It was a surprising development when Attorney General Pam Bondi announced on June 6 that officials were bringing Mr. Abrego Garcia back to the United States after weeks of insisting that the Trump administration was powerless to comply with a series of court orders — including one from the Supreme Court — to 'facilitate' his release from Salvadoran custody. The administration's stated reason for doing so was equally surprising: so that Mr. Abrego Garcia could stand trial, Ms. Bondi said, on serious charges of taking part in a yearslong conspiracy to smuggle undocumented immigrants across the United States. During a news conference in Washington, Ms. Bondi assailed Mr. Abrego Garcia as 'a smuggler of humans and children and women,' linking him to even more serious crimes like murder and drug trafficking. 'This is what American justice looks like,' Ms. Bondi said. 'Upon completion of his sentence, we anticipate he will be returned to his home country of El Salvador.' Want all of The Times? Subscribe.
Yahoo
25 minutes ago
- Yahoo
UnitedHealth appoints new CEO to run health services division
By Amina Niasse NEW YORK (Reuters) -UnitedHealth Group's health services segment, Optum Health, will be led by Patrick Conway, according to an internal company memo. A spokesperson for UnitedHealth said Conway's experience in value-based care, where payment is generated from keeping patients healthy, drove the health insurer's new appointment. 'Leadership changes are consistent with the company's longstanding, intentional approach to develop an executive team with a range of experiences across its diverse portfolio of businesses," the spokesperson said. The company named former Optum Health CEO Amar Desai as vice-chairman of the unit. UnitedHealth Group named a new company-wide CEO, veteran Stephen Hemsley, to steer the healthcare giant following its first earnings miss since 2008. Conway in April was appointed CEO of UnitedHealth's Optum segment, which operates its Optum Health unit, and previously ran its Optum Rx pharmacy benefit manager. Optum Health, which operates medical clinics and offers nursing services, serves as UnitedHealth's healthcare delivery arm. In a first-quarter earnings call, UnitedHealth detailed underperforming revenue at Optum Health, citing reduced engagement from Medicare Advantage patients. A May Wall Street Journal report detailed a criminal probe by the Department of Justice on UnitedHealth's billing practices, related to in-home visits it conducts within Optum Health. Hemsley in a June shareholder meeting said that the company was undertaking a review of practices across its business, apologizing for recent underperformance in earnings. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Bloomberg
26 minutes ago
- Bloomberg
Trump Administration to Review Contracts With Consulting Firms
The Trump administration is asking consulting firms to justify their federal contracts as part of far-reaching efforts to reduce waste in federal spending, according to a letter obtained by Bloomberg News. The US General Services Administration said in a letter dated Thursday that it is soliciting information from the firms about their contracts to help 'critically evaluate which engagements deliver genuine value and demonstrable returns to the American taxpayer, and therefore merit external support, and which should be internalized to ensure we are responsible stewards of taxpayer dollars and avoid unnecessary spending.'